CTOR CITIUS ONCOLOGY INC

Ownership history in MORGAN STANLEY  ·  1 quarter on record

This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in CITIUS ONCOLOGY INC (CTOR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 5 0.00% $10 $2.03
% of Fund (quarterly)    CTOR price (monthly, adj. close)
← Back to MORGAN STANLEY Holdings